Unter Knochendysplasie ist eine heterogene Gruppe von Knochenerkrankungen verstanden, die durch eine Fehlentwicklung entstehen.
1. |
Feuillan PP et al. (1986) Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. |
2. |
None (1970) Bones, stones and hormones: the contributions of Fuller Albright. |
3. |
Shires R et al. (1979) Idiopathic hypothalamic hypogonadotropic hypogonadism with polyostotic fibrous dysplasia. |
4. |
McArthur RG et al. (1979) Albright's syndrome with rickets. |
5. |
Hall R et al. (1972) Hypersecretion of hypothalamic releasing hormones: a possible explanation of the endocrine manifestations of polyostotic fibrous dysplasia (Albright's syndrome). |
6. |
None (1986) The McCune-Albright syndrome: a lethal gene surviving by mosaicism. |
7. |
Giovannelli G et al. (1978) McCune-Albright syndrome in a male child: a clinical and endocrinologic enigma. |
8. |
Kaplan FS et al. (1988) Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). |
9. |
Viljoen DL et al. (1988) Polyostotic fibrous dysplasia with cranial hyperostosis: new entity or most severe form of polyostotic fibrous dysplasia? |
10. |
None (1988) Osteosarcoma in fibrous dysplasia. |
11. |
Schey WL et al. (1971) Familial pubic bone maldevelopment. |
12. |
Döhler JR et al. (1986) Idiopathic hyperphosphatasia with dermal pigmentation. A twenty-year follow-up. |
13. |
Ehrich JH et al. (1990) Association of spondylo-epiphyseal dysplasia with nephrotic syndrome. |
14. |
Abs R et al. (1990) Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome. |
15. |
Zacharin M et al. (2011) Gastrointestinal polyps in McCune Albright syndrome. |
16. |
Hamilton CR et al. (1973) Unusual types of hyperthyroidism. |
17. |
None (1977) Fibrous dysplasia of bone. Report of female monozygotic twins with and without the McCune-Albright syndrome. |
19. |
Weinstein LS et al. (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. |
20. |
Elizondo LI et al. (2009) Schimke immuno-osseous dysplasia: SMARCAL1 loss-of-function and phenotypic correlation. |
21. |
Hashimoto K et al. (1994) Juvenile variant of Schimke immunoosseous dysplasia. |
22. |
Boerkoel CF et al. (1998) Schimke immunoosseous dysplasia complicated by moyamoya phenomenon. |
23. |
Kaitila I et al. (1998) Autoimmune enteropathy in Schimke immunoosseous dysplasia. |
24. |
Bianco P et al. (1998) Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. |
25. |
None (1998) "A rare disorder, yes; an unimportant one, never". |
26. |
Dent CE et al. (1976) Hypophosphataemic osteomalacia in fibrous dysplasia. |
27. |
Mastorakos G et al. (1997) Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. |
29. |
Ludman MD et al. (1993) Schimke immuno-osseous dysplasia: case report and review. |
30. |
Santavá A et al. (1994) Spondyloepiphyseal dysplasia with nephrotic syndrome (Schimke immunoosseous dysplasia). |
31. |
Taha D et al. (2004) Fatal lymphoproliferative disorder in a child with Schimke immuno-osseous dysplasia. |
32. |
Malchoff CD et al. (1994) An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion. |
33. |
Candeliere GA et al. (1995) Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. |
34. |
Cole DE et al. (1983) Panostotic fibrous dysplasia: a congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia. |
35. |
Alvarez-Arratia MC et al. (1983) A probable monogenic form of polyostotic fibrous dysplasia. |
36. |
Nager GT et al. () Fibrous dysplasia of the temporal bone. Update with case reports. |
37. |
Comite F et al. (1984) Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome. |
38. |
None (1966) Sex precocity and polyostotic fibrous dysplasia. Report of a case in a boy with testicular biopsy. |
39. |
Firat D et al. (1968) Fibrous dysplasia of the bone. Review of twenty-four cases. |
40. |
Wirth WA et al. (1971) Multiple intramuscular myxomas. Another extraskeletal manifestation of fibrous dysplasia. |
41. |
de Sanctis C et al. () McCune-Albright syndrome: a longitudinal clinical study of 32 patients. |
42. |
None (1975) Editorial: Albright syndrome: is it coming of age? |
43. |
Laven JS et al. (2001) Dynamics of ovarian function in an adult woman with McCune--Albright syndrome. |
44. |
Obuobie K et al. (2001) McCune-Albright syndrome: growth hormone dynamics in pregnancy. |
45. |
Coutant R et al. (2001) Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)alpha gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. |
46. |
Petty EM et al. (2000) Successful bone marrow transplantation in a patient with Schimke immuno-osseous dysplasia. |
47. |
None (2000) Dental findings in the Schimke immuno-osseous dysplasia. |
48. |
Sigurdardottir S et al. (2000) Mental retardation and seizure disorder in Schimke immunoosseous dysplasia. |
49. |
Boerkoel CF et al. () Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. |
50. |
Bianco P et al. (2000) Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. |
51. |
Mieszczak J et al. (2008) The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. |
52. |
Reitzik M et al. (1975) Familial polyostotic fibrous dysplasia. |
53. |
Saraiva JM et al. (1999) Schimke immuno-osseous dysplasia: case report and review of 25 patients. |
54. |
Kitoh H et al. (1999) Different genotype of periosteal and endosteal cells of a patient with polyostotic fibrous dysplasia. |
55. |
Kirk JM et al. (1999) Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. |
56. |
Tinschert S et al. (1999) McCune-Albright syndrome: clinical and molecular evidence of mosaicism in an unusual giant patient. |
57. |
Spranger J et al. (1991) Schimke immuno-osseous dysplasia: a newly recognized multisystem disease. |
58. |
Clewing JM et al. (2007) Schimke immunoosseous dysplasia: suggestions of genetic diversity. |
59. |
Clewing JM et al. (2007) Schimke immuno-osseous dysplasia: a clinicopathological correlation. |
60. |
Boerkoel CF et al. (2002) Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. |
61. |
Lou S et al. (2002) Longevity in Schimke immuno-osseous dysplasia. |
62. |
Baradaran-Heravi A et al. (2008) Clinical and genetic distinction of Schimke immuno-osseous dysplasia and cartilage-hair hypoplasia. |
63. |
Endo M et al. (1991) Monozygotic twins discordant for the major signs of McCune-Albright syndrome. |
64. |
Lücke T et al. (2007) Cerebellar atrophy in Schimke-immuno-osseous dysplasia. |
65. |
Yoshimoto M et al. (1991) A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. |
66. |
Feuillan P et al. (2007) Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. |
67. |
Schwindinger WF et al. (1991) DNA light on the Tegernsee giant. |
68. |
Nerlich A et al. (1991) Juvenile gigantism plus polyostotic fibrous dysplasia in the Tegernsee giant. |
69. |
Elizondo LI et al. (2006) Schimke immuno-osseous dysplasia: a cell autonomous disorder? |
70. |
Schwindinger WF et al. (1992) Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. |
71. |
Lumbroso S et al. (2004) Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study. |
72. |
Lücke T et al. (2004) Generalized atherosclerosis sparing the transplanted kidney in Schimke disease. |
73. |
Laven JS et al. (2004) Management of infertility in a patient presenting with ovarian dysfunction and McCune-Albright syndrome. |
74. |
Plotkin H et al. (2003) Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. |
75. |
Premawardhana LD et al. (1992) Acromegaly and its treatment in the McCune-Albright syndrome. |
77. |
None (1992) Tegernsee giant. |
78. |
HIBBS RE et al. (1952) [Albright's syndrome]. |
79. |
Collins MT et al. (2003) Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. |
80. |
Akintoye SO et al. (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. |
81. |
Orphanet article Orphanet ID 2763 |